Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical experience on aztreonam].

K Seki, H Nakamura, Y Iwata

    The Japanese Journal of Antibiotics
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Semidiscoid lateral meniscus].

    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
    Same author

    [Abnormal chest shadow on CT in immunosuppressed patients].

    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
    Same author

    [MR imaging evaluation of plica synoviallis mediopatellaris of the knee joint].

    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
    Same author

    Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations.

    Biochemistry·1992
    Same author

    Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene.

    FEBS letters·1992
    Same author

    Inhibition of passive cutaneous anaphylaxis by synthetic human immunoglobulin E peptide fragments.

    FEBS letters·1992

    Aztreonam (AZT), a novel monobactam antibiotic, demonstrated significant efficacy in treating gynecologic infections. This study found AZT effective in over 76% of patients with conditions like adnexitis and pelvic peritonitis.

    Area of Science:

    • Gynecology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Gynecologic infections pose significant health challenges.
    • Novel antibiotic agents are crucial for combating resistant pathogens.

    Observation:

    • Aztreonam (AZT), a monobactam antibiotic, was evaluated for clinical efficacy.
    • The study included patients diagnosed with adnexitis, pelvic peritonitis, endometritis, and wound abscess.
    • AZT was administered intravenously at 2g daily in divided doses.

    Findings:

    • Aztreonam achieved an overall efficacy rate of 76.9% in treating gynecologic infections.
    • Ten out of thirteen patients showed a good clinical response.
    • Transient, mild elevations in liver enzymes (GOT, GPT, Al-P) were noted in one patient, resolving post-therapy.

    Related Experiment Videos

    Implications:

    • Aztreonam presents a promising therapeutic option for gynecologic infections.
    • The antibiotic exhibits a favorable safety profile with minimal side effects.
    • Further research may explore AZT's role in broader gynecologic and obstetric infectious disease management.